Results 151 to 160 of about 1,388,067 (303)

Real‐World Safety and Efficacy of Pola‐R‐CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients

Cancer Science, EarlyView.
In this analysis of a diverse cohort of 500 patients with previously untreated DLBCL in a real‐world clinical setting, Pola‐R‐CHP demonstrated high response rates at end‐of‐treatment, which were consistent among the overall population, in patients > 80 years and regardless of International Prognostic Index status and cell of origin subtypes.
Takahiro Kumode, Hitomi Sawa, Kohta Miyawaki, Atsushi Satake, Nobuhiro Kanemura, Ritsuro Suzuki, Yuki Fujiwara, Yasuhiro Nagate, Shuichi Ota, Takahiro Fujino, Hideki Goto, Noriko Fukuhara, Mamiko Sakata‐Yanagimoto, Koji Izutsu, Momoko Nishikori, Hirohiko Shibayama, Daisuke Ennishi, Takayuki Shimose, Mai Asai, Itaru Matsumura, Koichi Akashi, Koji Kato   +21 more
wiley   +1 more source

A De Novo ATP1A3 p.Arg995His Variant in a Patient With an Adult‐Onset Primary Lateral Sclerosis‐Like Syndrome

Clinical Genetics, EarlyView.
A 43‐year‐old woman developed a progressive adult‐onset upper motor neuron syndrome fulfilling the clinical criteria for primary lateral sclerosis (PLS), with mild cerebellar involvement. Genetic testing identified a de novo ATP1A3 p.Arg995His variant affecting a highly conserved residue within the transmembrane M8 domain.
Pablo Hernandez‐Vitorique, Marta García de Burgos, Ana Campos Villegas, María José Gómez Heredia, Pilar Carbonell Corvillo   +4 more
wiley   +1 more source

Epstein-Barr virus-associated smooth muscle tumour: two case reports [PDF]

Epstein-Barr virus-associated smooth muscle tumour (EBV-SMT) is an intermediate mesenchymal neoplasm recognised in immunocompromised patients, including HIV-infected patients.
Abdul Kahar, Nor Farahin, Abd Rani, Nor Haizura, Mohd Dusa, Noraini, Hussin, Huzlinda   +3 more
core   +2 more sources

Rapidly Progressive and Severe Hemolytic Anemia Associated With Epstein-Barr Virus: A Case Report [PDF]

Angela Torijano, MARIA CAMILA TOLE, Patxis Taveras, Sangam Sangam, Ivette Sara Vigoda   +4 more
openalex   +1 more source

Aberrant Expression of Multiple T‐Cell Markers in Primary Cutaneous Follicle Center Lymphoma: A Rare Case Report

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Aberrant expression of T‐cell markers in B‐cell lymphomas is rare and can pose diagnostic challenges. We report a case of a 65‐year‐old man presenting with newly developed scalp nodules. Histopathology revealed nodular lymphoid infiltrates composed of large centrocytes and centroblasts.
V. Pfefferle, A. Vogelsberg, M. Maaß, C. M. Schürch, S. Forchhammer   +4 more
wiley   +1 more source

Epstein-Barr Virus: More than Just an Infection. [PDF]

Viruses
Van de Perre E, Van Nieuwenhuyse B, Yombi JC.   +2 more
europepmc   +1 more source

Cervical lymph node B cell subset resists depletion and sustains lytic Epstein Barr-virus signature in patients with multiple sclerosis

Yigit Koray Babal, Joona Sarkkinen, Ella Ahvenainen, Annika Susi, Mika Saarela, Goran Kurdo, Sini M. Laakso   +6 more
openalex   +1 more source

Epstein-Barr Virus in HIV-Associated Conjunctival Squamous Cell Carcinoma and Transcriptional Reprogramming of Conjunctival Epithelial Cells [PDF]

Hirotomo Dochi, Janardhan Avilala, Yutaro Yamada, Masayuki Takahira, Satoru Kondo, Tomokazu Yoshizaki, Maria Morales, Ramsy Abdelghani, David Becnel, Mark Sides, Gilbert F. Morris, Wenke Feng, Hong Liu, Zhen Nan Lin   +13 more
openalex   +1 more source

Modulation of DNA Damage by Epstein-Barr Virus (EBV). [PDF]

Viruses
DiMaulo-Milk E, Damania B.
europepmc   +1 more source

A comparative analysis of cell death signalling in RNA and DNA virus infections and potential inhibitory strategies

The FEBS Journal, EarlyView.
RNA and DNA viruses can manipulate host cell death through various mechanisms. RNA viruses (H1N1, SARS‐CoV‐2) induce acute apoptosis, necroptosis, and pyroptosis to promote rapid viral transmission and epithelial barrier damage. In contrast, DNA viruses (HSV‐1, EBV) regulate these mechanisms to sustain a lytic‐latency cycle, evade immune response and ...
Panagiotis Keramidas, Maria Pitou, Amalia Aggeli, Sotiris Varlamis, Theodora Choli‐Papadopoulou   +4 more
wiley   +1 more source